References
- Liebson P R. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens 1990; 3: 512–7
- Lavie C J, Ventura H O, Messerli F H. Regression of increased left ventricular mass by antihypertensives. Drugs 1991; 42: 945–61
- Schulman S P, Weiss J L, Becker L C, Affer Becker L C, Gottlieb S O, Woodruff K M, Weisfeldt M SN, Gerstenblith G. The effects of anti-hypertensive therapy on left ventricular mass in elderly patients. New Engl J Med 1990; 322: 1350–6
- Henry W L, Clark L E, Epstein S E. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of idiopathic hypertrophic subaortic stenosis. Circulation 1973; 47: 225–33
- Sahn D J, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation of M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–83
- Otterstad J E, Froeland G, Wasenius Soeyland A K, Knutsen K M, Ekeli T. Changes in left ventricular dimensions and systolic function in 100 mildly hypertensive men during one year's treatment with atenolol vs. hydrochlorothiazide and amiloride (Moduretic): a double blind, randomized study. J Intern Med 1992; 231: 493–501
- Strauer B E, Mahmoud M A, Bayer F, Bohm I, Motz U. Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine. Eur Heart J 1984; 5(suppl F)53–60
- Otterstad J E, Froeland G, Michelsen S, Wasenius A K, Knutsen K M, Stugaard M. Differences in left ventricular end-diastolic dimensions when measured at the Q wave or P wave in normal versus moderately hypertensive men. Am J Noninvas Cardiol 1990; 4: 358–63
- Devereux R B, Reichek N. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1977; 55: 613–8
- Du Bois D, Du Bois E F. Clinical calorimetry. A formula to estimate the approximate surface area if height and weight are known. Arch Int Med 1916; 17: 863–71
- Savage D D, Devereux R B. Echocardiography and hypertension. Prim Cardiol 1981; 7: 137–52
- Rechek N. Devereux RB: Reliable estimation of peak left ventricular systolic pressure by M-mode echocardiographic-determined end-diastolic relative wall thickness: identification of severe aortic stenosis in adult patients. Am Heart J 1982; 103: 202–9
- Otterstad J E, Hurlen M, Michelsen S, Knutsen K M. Reproducibility of serial M-mode and Dop-pler echocardiographic recordings of left ventricular dimensions and function: a comparison with traditional measurements of heart rate and blood pressure in apparently healthy men. J Cardiovasc Ultrasonography 1987; 6: 285–95
- Dahlöf B, Pennert K, Hansson L. Reversal of left véntricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies. Am J Hypertens 1992; 5: 95–110
- Otterstad J E, Michelsen S, Froeland G, Stugaard M. A comparison between the anti-hypertensive effects of atenolol 50 mg and co-amiloride (hydrochlorothiazide 25 mg + amiloride 5mg) during bicycle ergometer exercise testing. J Drug Dev 1992; 5: 27–33
- Cruickshank J M, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Human Hypertens 1992; 6: 85–90
- Troy B L, Pombo J, Rackley C E. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation 1972; 45: 602–11
- Reichek N, Deverux R B. Left ventricular hypertrophy relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 1981; 63: 1391–8
- Koren M J, Devereux R B, Casale P N, Savage D D, Laragh J H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Int Med 1991; 114: 345–52